GLP-1 side effects: What's normal and when to call your doctor

GLP-1 receptor agonists — including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Victoza, Saxenda) — have changed the landscape of diabetes management and medical weight loss. But like every medication, they come with a side effect profile that patients deserve to understand clearly before starting. Most side effects are manageable. A few are serious. Knowing the difference helps you stay safe and get the most out of treatment.

Many GLP-1 side effects—especially GI symptoms—are dose-dependent. Our complete guide to semaglutide dosing explains how titration works and why going slow matters.

Side effects can vary by formulation. Our comparison of injectable versus oral GLP-1 medications covers how side effect profiles differ.

How GLP-1 medications work — and why side effects happen

GLP-1 receptor agonists mimic a naturally occurring gut hormone that regulates insulin secretion, slows gastric emptying, and suppresses appetite. The same mechanism that makes these drugs effective — slowing the movement of food through the digestive tract — is also responsible for most of their side effects. When the stomach empties more slowly, nausea, bloating, and discomfort are common, especially early in treatment.

Common side effects: what to expect

The most frequently reported side effects of GLP-1 medications are gastrointestinal:

• Nausea — the most common side effect, affecting up to 44% of users at some doses. It is usually most intense after a dose increase and improves within a few weeks.
• Vomiting — less common than nausea, but present in a meaningful percentage of users, particularly at higher doses.
• Diarrhea — occurs in approximately 8–30% of users depending on the specific medication.
• Constipation — counterintuitively, some patients experience constipation rather than diarrhea, particularly with tirzepatide.
• Bloating and burping — common, and largely a consequence of slowed gastric emptying.

These symptoms are real and can interfere with daily life, but they are not dangerous for most people. The standard approach is to stick with the prescribed titration schedule, eat smaller meals, avoid high-fat and high-sugar foods that worsen nausea, and give the body time to adjust. Skipping dose escalation steps to avoid side effects is a common mistake — the titration schedule exists precisely to minimize GI distress.

Injection site reactions

Because GLP-1 medications are administered subcutaneously (just under the skin), injection site reactions are common. Redness, itching, bruising, and minor swelling at the injection site typically resolve within a few days. Rotating injection sites with each dose — cycling between the abdomen, thigh, and upper arm — significantly reduces the frequency and severity of these reactions. If a site develops persistent hardness or a nodule (lipohypertrophy), avoid injecting in that area and notify your provider.

Side effects that require a call to your provider

Some side effects warrant prompt contact with the prescribing provider even if they don't require emergency care:

• Nausea or vomiting severe enough to prevent adequate fluid or food intake for more than 24 hours
• Persistent abdominal pain or bloating that doesn't improve
• Significant constipation not responding to dietary adjustment
• Symptoms of low blood sugar (shakiness, sweating, confusion) — more likely in patients also taking insulin or sulfonylureas
• Changes in vision — GLP-1 medications can cause rapid changes in blood sugar that temporarily affect vision in some patients with diabetes

Serious side effects: when to seek immediate care

A small number of GLP-1 side effects are serious and require same-day evaluation:

Pancreatitis: Severe, persistent abdominal pain — often described as radiating from the abdomen through to the back — with nausea and vomiting may indicate pancreatitis (inflammation of the pancreas). This is a known rare risk with GLP-1 medications. Stop the medication and go to urgent care or the ER immediately. Do not resume without clearance from your provider.

Gallbladder disease: Rapid weight loss (which GLP-1 medications facilitate) is a known risk factor for gallstone formation. Symptoms of gallstones or cholecystitis include right upper abdominal pain, especially after eating fatty foods, and possibly jaundice (yellowing of the skin or eyes). These symptoms warrant same-day evaluation.

Acute kidney injury: Severe GI side effects causing dehydration can stress the kidneys. Decreased urination, swelling, or extreme fatigue alongside GI symptoms warrants prompt medical assessment.

Allergic reactions: Severe rash, swelling of the face or throat, or difficulty breathing after injection requires immediate emergency care.

FDA black box warning: thyroid cancer risk

All GLP-1 receptor agonists approved in the United States carry an FDA black box warning about the risk of thyroid C-cell tumors, based on studies in rodents. Whether this risk translates to humans is not yet fully established, but the FDA has determined the warning is warranted. People with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use these medications. Discuss any family history of thyroid cancer with your provider before starting a GLP-1.

Tips for managing side effects day to day

• Eat small, frequent meals rather than large ones
• Avoid greasy, fried, or very sweet foods, which worsen nausea
• Stay well hydrated — dehydration worsens both GI symptoms and fatigue
• Inject at the same time each week to maintain consistency
• Keep a symptom diary to share with your provider at follow-up visits

When to visit urgent care

In cases of severe nausea or vomiting leading to dehydration, urgent care can help—read about getting IV fluids at urgent care when dehydration becomes a concern.

Urgent care is an appropriate first stop if you're experiencing dehydration from persistent nausea or vomiting, abdominal pain that concerns you, or an injection site that looks infected. Providers can assess your symptoms, run labs, and administer IV fluids if needed. If you have severe abdominal pain radiating to your back, jaundice, or signs of a serious allergic reaction, go directly to the ER. For all questions about your ongoing GLP-1 prescription, dosing, or titration, contact your prescribing provider.